FDA Issues New Conflict Of Interest Guidelines

Law360, New York (August 5, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has announced new policies aimed at lessening conflicts of interest on its advisory committees.

The rules announced Monday include limits on a board member's financial interests in a company whose drug is being vetted, altered voting procedures and increased public disclosure of advisory committees' findings. They also include changes to the internal procedures of advisory committees.

“The FDA’s regulatory decisions affect the health of millions of Americans, and we don’t make those decisions in a vacuum,” FDA Deputy Commissioner for...
To view the full article, register now.